Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevention of zoonotic spillover: From relying on response to reducing the risk at source.
Authored by the members of the One Health High-Level Expert Panel (OHHLEP); Markotter W, Mettenleiter TC, Adisasmito WB, Almuhairi S, Barton Behravesh C, Bilivogui P, Bukachi SA, Casas N, Cediel Becerra N, Charron DF, Chaudhary A, Ciacci Zanella JR, Cunningham AA, Dar O, Debnath N, Dungu B, Farag E, Gao GF, Hayman DTS, Khaitsa M, Koopmans MPG, Machalaba C, Mackenzie JS, Morand S, Smolenskiy V, Zhou L. Authored by the members of the One Health High-Level Expert Panel (OHHLEP), et al. Among authors: koopmans mpg. PLoS Pathog. 2023 Oct 5;19(10):e1011504. doi: 10.1371/journal.ppat.1011504. eCollection 2023 Oct. PLoS Pathog. 2023. PMID: 37796834 Free PMC article. No abstract available.
One Health action for health security and equity.
One Health High-Level Expert Panel. One Health High-Level Expert Panel. Lancet. 2023 Feb 18;401(10376):530-533. doi: 10.1016/S0140-6736(23)00086-7. Epub 2023 Jan 19. Lancet. 2023. PMID: 36682373 Free PMC article. No abstract available.
Developing One Health surveillance systems.
One Health High-Level Expert Panel (OHHLEP); Hayman DTS, Adisasmito WB, Almuhairi S, Behravesh CB, Bilivogui P, Bukachi SA, Casas N, Becerra NC, Charron DF, Chaudhary A, Ciacci Zanella JR, Cunningham AA, Dar O, Debnath N, Dungu B, Farag E, Gao GF, Khaitsa M, Machalaba C, Mackenzie JS, Markotter W, Mettenleiter TC, Morand S, Smolenskiy V, Zhou L, Koopmans M. One Health High-Level Expert Panel (OHHLEP), et al. One Health. 2023 Aug 21;17:100617. doi: 10.1016/j.onehlt.2023.100617. eCollection 2023 Dec. One Health. 2023. PMID: 38024258 Free PMC article. Review.
The One Health High-Level Expert Panel (OHHLEP).
Mettenleiter TC, Markotter W, Charron DF, Adisasmito WB, Almuhairi S, Behravesh CB, Bilivogui P, Bukachi SA, Casas N, Becerra NC, Chaudhary A, Zanella JRC, Cunningham AA, Dar O, Debnath N, Dungu B, Farag E, Gao GF, Hayman DTS, Khaitsa M, Koopmans MPG, Machalaba C, Mackenzie JS, Morand S, Smolenskiy V, Zhou L. Mettenleiter TC, et al. Among authors: koopmans mpg. One Health Outlook. 2023 Dec 7;5(1):18. doi: 10.1186/s42522-023-00085-2. One Health Outlook. 2023. PMID: 38062534 Free PMC article. No abstract available.
Correction: The One Health High-Level Expert Panel (OHHLEP).
Mettenleiter TC, Markotter W, Charron DF, Adisasmito WB, Almuhairi S, Behravesh CB, Bilivogui P, Bukachi SA, Casas N, Becerra NC, Chaudhary A, Ciacci Zanella JR, Cunningham AA, Dar O, Debnath N, Dungu B, Farag E, Gao GF, Hayman DTS, Khaitsa M, Koopmans MPG, Machalaba C, Mackenzie JS, Morand S, Smolenskiy V, Zhou L. Mettenleiter TC, et al. Among authors: koopmans mpg. One Health Outlook. 2024 Mar 27;6(1):6. doi: 10.1186/s42522-024-00096-7. One Health Outlook. 2024. PMID: 38539273 Free PMC article. No abstract available.
The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment.
Imhof C, Messchendorp AL, Bungener LB, Hepkema BG, Kho MML, Reinders MEJ, Bemelman FJ, Hilbrands LB, Gansevoort RT, Sanders JSF; RECOVAC Consortium. Imhof C, et al. Clin Kidney J. 2024 Apr 25;17(5):sfae122. doi: 10.1093/ckj/sfae122. eCollection 2024 May. Clin Kidney J. 2024. PMID: 38770045 Free PMC article. No abstract available.
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.
Zaeck LM, Tan NH, Rietdijk WJR, Geers D, Sablerolles RSG, Bogers S, van Dijk LLA, Gommers L, van Leeuwen LPM, Rugebregt S, Goorhuis A, Postma DF, Visser LG, Dalm VASH, Lafeber M, Kootstra NA, Huckriede ALW, Haagmans BL, van Baarle D, Koopmans MPG; SWITCH-ON Research Group; van der Kuy PHM, GeurtsvanKessel CH, de Vries RD. Zaeck LM, et al. Among authors: koopmans mpg. Nat Commun. 2024 May 18;15(1):4224. doi: 10.1038/s41467-024-48414-x. Nat Commun. 2024. PMID: 38762522 Free PMC article. Clinical Trial.
An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution.
Subissi L, Otieno JR, Worp N, Attar Cohen H, Oude Munnink BB, Abu-Raddad LJ, Alm E, Barakat A, Barclay WS, Bhiman JN, Caly L, Chand M, Chen M, Cullinane A, de Oliveira T, Drosten C, Druce J, Effler P, El Masry I, Faye A, Ghedin E, Grant R, Haagmans BL, Happi C, Herring BL, Hodcroft EB, Ikejezie J, Katawera V, Kassamali ZA, Leo YS, Leung GM, Kondor RJ, Marklewitz M, Mendez-Rico J, Melhem NM, Munster V, Nahapetyan K, Naindoo D, Oh DY, Peacock TP, Peiris M, Peng Z, Poon LLM, Rambaut A, Saha S, Shen Y, Siqueira MM, Volz E, Tessema SK, Thiel V, Triki H, van der Werf S, von Eije K, Cunningham J, Koopmans MPG, von Gottberg A, Agrawal A, Van Kerkhove MD. Subissi L, et al. Among authors: koopmans mpg. Nat Med. 2024 May 8. doi: 10.1038/s41591-024-02949-0. Online ahead of print. Nat Med. 2024. PMID: 38720002 No abstract available.
310 results